Evidence map›Paper›PMID 23468368›Full record

ArticleEuropean journal of immunology2013

Development of CD27+ marginal zone B cells requires GALT.

Venkata A Yeramilli, Katherine L Knight

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. The B cell helper side of neutrophils.Journal of leukocyte biology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Venkata A YeramilliDepartment of Microbiology and Immunology, Loyola University, Chicago, IL, USA.
Katherine L Knight
Loyola University Chicago · US

Funding

Somatic Diversification of Immunoglobulin Genes in GALTR01AI050260 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI KNIGHT, KATHERINE L. · 2001 to 2015
$5.1M
Maintaining B cell immunity with aged B lymphocytesR01AI068390 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI KNIGHT, KATHERINE L. · 2007 to 2015
$3.4M
NIAID NIH HHS AI068390NIAID NIH HHS AI50260NIAID NIH HHS R01 AI050260NIAID NIH HHS R01 AI068390
6 · The paper itself

Abstract

In species other than mouse, little is known about the origin and development of marginal zone (MZ) B cells. Using cross-reactive antibodies, we identified and characterized splenic MZ B cells in rabbits as CD27(+) CD23(-). In rabbits in which organized gut-associated lymphoid tissue (GALT) was surgically removed at birth, we found only CD23(+) follicular (FO) B cells and almost no CD27(+) MZ B cells in the spleen, indicating that GALT is required for the development of splenic MZ B cells. These findings lead us to suggest that commensal microbiota contribute to the development of MZ B cells.

Indexed as

AnimalsAnimals, NewbornB-LymphocytesCell DifferentiationIntestinesLymphoid TissueMetagenomeMiceRabbitsReceptors, IgESpleenTumor Necrosis Factor Receptor Superfamily, Member 7Receptors, IgETumor Necrosis Factor Receptor Superfamily, Member 7

Identifiers

PMID23468368
PMCPMC3757504
OpenAlexW1707213793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.